Brandx Medica – Official Launch Announcement

SCOTTSDALE, Ariz., Oct. 4, 2019 /PRNewswire/ — On October 2nd, 2019, Brandx Medica announced its official launch, opening patient acquisition services for doctors and medical practices in Scottsdale, Arizona, Beverly Hills, California, New York City, New York, and Las Vegas, Nevada.

Brandx Medica’s Founder and CEO, Dustin Capp, says, “We understand that doctors need to focus on their customer experience and patient care. This is why we’ve created a platform to leverage patient acquisition on a robust level, allowing our doctor clients to focus on what’s most important.”

Brandx Medica has been attracting high intent patients for medical practices by building a proprietary search algorithm. This algorithm leverages PPC (pay per click), and social campaigns to connect patients with medical practices that ultimately increase conversions and patient influx each month.

Additionally, the company is launching with an inbound call center trained on catering towards patients who are looking to schedule a visit with their doctor or medical practice, creating a seamless client experience from internet search to a physical appointment.

Capp continued to say, “What’s unique is that the doctors and medical practices can choose how many new patients they want each month. It’s important for us to give our clients the ability to scale at a rate that’s in correlation with their bandwidth.”

Brandx Medica is accepting 4 new doctors and medical practice clients in Q4. Initially slated to service Arizona, California, New York, and Nevada, the company plans to expand in 2020. 

Starter practices under 1 million dollars in annual revenue can leverage their scalable model to help practices achieve their financial goals.

Media Contact: Dustin Capp, Dustin@brandxmedica.com

Website: https://activated.brandxmedica.com/robust-patient-acquisition/

View original content:http://www.prnewswire.com/news-releases/brandx-medica—official-launch-announcement-300931347.html

SOURCE Brandx Medica

Staff

Recent Posts

KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of RYSTIGGO® (rozanolixizumab-noli), Expanding Label for FreedomEDGE® Infusion System

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading…

3 hours ago

Hologic Announces Financial Results for First Quarter of Fiscal 2026

– Revenue of $1,047.8 Million Grows 2.5% – – GAAP Diluted EPS of $0.79 Decreases…

3 hours ago

Illumina completes acquisition of SomaLogic

Deeply expands leadership in proteomics and multiomicsCombined capabilities bring high scalability, flexibility, and affordability into protein…

3 hours ago

RazorMetrics Drives More Than $11 Million in Prescription Drug Savings for Ohio Plans and Residents

AUSTIN, Texas, Jan. 30, 2026 /PRNewswire/ -- RazorMetrics, a leading innovator in pharmacy cost containment…

3 hours ago

NYSE Content Advisory: Pre-Market Update + Cast of HBO’s ‘Industry’ Rang Thursday’s Closing Bell

NEW YORK, Jan. 30, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a…

3 hours ago

VolitionRx Limited Announces the Preparation of Reimbursement Submission for its Nu.Q® Cancer Assays

HENDERSON, Nev., Jan. 30, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national…

3 hours ago